Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Bigham currently holds 228,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Bigham has been a net seller of PRTK stock. They have purchased $458.2K and sold $2.2M worth of shares.
Michael Bigham's most recent insider trade was on Sep 21, 2023, when they sold 228,750 shares at $0.00 per share.
Michael Bigham serves as Executive at Paratek Pharmaceuticals, Inc. (PRTK). They have executed 63 insider transactions totaling $2.7M over their tenure at the company.
Michael Bigham holds the position of Executive at Paratek Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Michael Bigham has shown a selling trading pattern, with $458.2K in total purchases and $2.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Bigham was on Jun 4, 2021, when they sold $333.3K worth of PRTK shares. This transaction involved 34,364 shares at $9.70 per share.
Michael Bigham currently owns 228,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Bigham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Bigham has 63 Form 4 filings on record as an insider at Paratek Pharmaceuticals, Inc..
Set alerts for Michael Bigham and 40,000+ other insiders.